Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Patent
1999-02-25
2000-01-25
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
544 581, 562426, A61K 3169
Patent
active
060179023
ABSTRACT:
The present invention provides new boron containing amino acid compounds and methods for making these compounds by contacting melphalan or another nitrogen mustard derivative and sodium borocaptate. The present invention also provides a method of treating a mammal having a tumor by administering to the mammal a therapeutically effective amount of the new boron containing amino acid compounds.
REFERENCES:
patent: 4332647 (1982-06-01), Goldenberg
patent: 4587359 (1986-05-01), Spielvogel et al.
patent: 4824659 (1989-04-01), Hawthorne
patent: 4977268 (1990-12-01), McPhail et al.
patent: 5466679 (1995-11-01), Soloway et al.
patent: 5599796 (1997-02-01), Schinazi et al.
patent: 5679322 (1997-10-01), Wilbur
Capala et al., "Accumulation of Boron in Malignant and Normal Cells Incubated In Vitro with Boronophenylalanine, Mercaptoborane or Boric Acid", Radiation Research, 146:554-560 (1996).
Coderre et al., "Neutron Capture Therapy of the 9L Rat Glisarcoma Using the P-Boronophenylalanine-Fructose Complex", Int. J. Radiation Oncology Biol. Phys., 30:643-652 (1994).
Coderre et al., "Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results", Journal of Neuro-Oncology, 33:141-152 (1997).
Ralph G. Fairchild, "Microanalytical techniques for boron analysis using the .sup.10 B(n,.alpha.).sup.7 Li reaction", Med. Phys. 13:1 (1986).
Coderre et al., "Selective Delivery of Boron by the Melanin Precursor Analogue p-Boronophenylalanine to Tumors Other Than Melanoma.sup.1 ", Cancer Research, 50:138-141 (1990).
Miura et al, "Synthesis of a Nickel Tetracarboranylphenylporphyrin for Boron Neutron-Capture Therapy: Biodistribution and Toxicity in Tumor-Bearing Mice", Int. J. Cancer, 68:114-119 (1996).
Miura et al, "Biodistribution and Toxicity of 2,4-Divinyl-Nido-o-Carboranyldeuteroporphyrin IX in Mice", Biochemical Pharmacology, 43:467-476 (1992).
Coderre Jeffrey A.
Glass John D.
Bogosian Margaret C.
Brookhaven Science Associates
O'Sullivan Peter
LandOfFree
Boron containing amino acid compounds and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Boron containing amino acid compounds and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boron containing amino acid compounds and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316033